MUSECHEM: PREMIER PROVIDER OF SPECIALTY CHEMICALS AND SERVICES

The MAPK/ERK signaling pathway is an additional critical target for inhibitors. This pathway is associated with controling cell survival, development, and differentiation. Inhibitors targeting MAPK/ERK are employed in cancer cells treatments to prevent unrestrained cell expansion and lump development. In a similar way, JAK/STAT signaling inhibitors